UCB
UCB Pharma operates as a biopharmaceutical company with a focus on neurology and immunology diseases. The company leverages scientific advances and skills in areas such as genetics, biomarkers, and human biology.
UCB
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1928-01-01
Address:
Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Country:
Belgium
Website Url:
http://www.ucb.com
Total Employee:
10001+
Status:
Active
Contact:
(322) 559-9999
Email Addresses:
[email protected]
Total Funding:
202.21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Bayer
Bayer offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Mayne Pharma
Mayne Pharma Group, a specialist pharmaceutical company, optimizes and delivers oral drugs.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Purdue Pharma
Purdue Pharma L.P., a pharmaceutical company committed to improving patients' lives and serving the healthcare community.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is EBR:UCB
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-19 | Zogenix | Zogenix acquired by UCB | 1.9 B USD |
| 2020-11-12 | Handl Therapeutics | Handl Therapeutics acquired by UCB | N/A |
| 2020-06-05 | Engage Therapeutics | Engage Therapeutics acquired by UCB | 270 M USD |
| 2019-10-10 | Ra Pharmaceuticals | Ra Pharmaceuticals acquired by UCB | 2.1 B USD |
| 2018-04-05 | Element Genomics | Element Genomics acquired by UCB | 30 M USD |
| 2017-06-06 | Beryllium Discovery | Beryllium Discovery acquired by UCB | N/A |
| 2011-11-22 | Lectus Therapeutics | Lectus Therapeutics acquired by UCB | N/A |
| 2006-09-25 | Schwarz Pharma AG | Schwarz Pharma AG acquired by UCB | 4.4 M EUR |
| 2006-01-01 | Intranasal Therapeutics | Intranasal Therapeutics acquired by UCB | N/A |
| 2004-05-18 | Celltech Therapeutics | Celltech Therapeutics acquired by UCB | N/A |
Investors List
Financière de Tubize SA
Financière de Tubize SA investment in Post-IPO Equity - UCB
Paul Capital
Paul Capital investment in Post-IPO Equity - UCB
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-01-13 | Nile AI | UCB investment in Corporate Round - Nile AI | 25 M EUR |
| 2019-02-05 | Aetion | UCB investment in Series B - Aetion | 27 M USD |
| 2018-09-25 | Ceribell | UCB investment in Series B - Ceribell | 35 M USD |
| 2018-06-13 | StrideBio | UCB investment in Series A - StrideBio | 15.7 M USD |
| 2015-06-23 | Clementia Pharmaceuticals | UCB investment in Venture Round - Clementia Pharmaceuticals | 60 M USD |
| 2014-08-19 | Dermira | UCB investment in Series C - Dermira | 51 M USD |
| 2010-10-12 | Synosia Therapeutics | UCB investment in Series C - Synosia Therapeutics | 30 M USD |
Newest Events participated
Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany
on 2017-11-06 as exhibitor
Participated in Digital Health World Congress 2017
on 2017-05-23 as sponsor
Official Site Inspections
http://www.ucb.com Semrush global rank: 520.69 K Semrush visits lastest month: 93.66 K
- Host name: 20.123.173.188
- IP address: 20.123.173.188
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 